 RattanIndia Power Ltd consolidated Q2FY26 loss at Rs. 31.55 crores
RattanIndia Power Ltd consolidated Q2FY26 loss at Rs. 31.55 crores Dr Lal Path Labs Ltd reports Rs. 150.6 crores consolidated profit in Q2 FY26
Dr Lal Path Labs Ltd reports Rs. 150.6 crores consolidated profit in Q2 FY26 Sammaan Capital Ltd consolidated Q2 FY2025-26 net profit at Rs. 308.47 crores
Sammaan Capital Ltd consolidated Q2 FY2025-26 net profit at Rs. 308.47 crores Aptus Value Housing Finance India Ltd Q2 FY2026 consolidated PAT higher at Rs. 226.54 crores
Aptus Value Housing Finance India Ltd Q2 FY2026 consolidated PAT higher at Rs. 226.54 crores Sigma Solve Ltd Q2 FY2026 consolidated profit up at Rs. 6.64 crores
Sigma Solve Ltd Q2 FY2026 consolidated profit up at Rs. 6.64 crores 
              The equity shares of Fortis Healthcare Ltd (Symbol: FORTIS) shall be listed and admitted to dealings on the National Stock Exchange w.e.f. May 9, 2007. Trading shall be in the Normal Market Segment - Compulsory Demat (Rolling Settlement) for all investors.
Bombay Stock Exchange has announced that effective from Wednesday, May 9, 2007 the equity shares of Fortis Healthcare Ltd (Scrip Code: 532843) shall be listed and admitted to dealings on the Exchange in the list of B1 Group.
The company issued shares at a price of Rs. 108 Per share (Face Value of Rs. 10/- and Premium of Rs.98). The Registrar to the issue is Intime Spectrum Registry Ltd.